ASTRO

This page includes the latest news from the American Society of Radiation Oncology (ASTRO), including news and video coverage from the society's annual meeting. ASTRO is the premier radiation oncology society in the world, with more than 10,000 members who are physicians, nurses, biologist, physicists, radiation therapists, dosimetrists and other healthcare professionals who specialize in treating patients with radiation therapy. 

Videos | Radiation Oncology
VIDEO: Calculating the Cost of Prior Authorizations Required for Radiation Oncology

Brian S. Bingham, M.D., chief resident in radiation oncology at the Vanderbilt University Medical Center, explains the ...

Time February 02, 2022
arrow
Videos | Radiation Therapy
VIDEO: Use of Radiation Therapy as a Bridge-to-transplant in Liver Cancer

Nima Nabavizadeh, M.D., radiation oncologist and associate professor of radiation medicine, Oregon Health and Science ...

Time February 02, 2022
arrow
Videos | Radiation Oncology
VIDEO: How to Manage the Complex Needs of Pelvic Radiotherapy Patients

Bridget F. Koontz, M.D., chief medical officer at GenesisCare USA explains how to manage the complex needs of pelvic ...

Time February 02, 2022
arrow
Videos | Radiation Oncology
VIDEO: 3-D Virtual Reality Aids Patient Understanding of Their Cancer and Therapy

Douglas E. Holt, M.D., a radiation oncologist at Eastern Idaho Regional Medical Center, explains the use of 3-D virtual ...

Time February 02, 2022
arrow
A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation therapy to treat adult patients with primary liver cancers using external beam radiation therapy (EBRT).
News | Radiation Therapy
ASTRO Issues Clinical Guideline on External Beam Radiation Therapy for Primary Liver Cancers

January 13, 2022 — A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance ...

Time January 13, 2022
arrow
Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that the first patient has been enrolled in NANORAY-312, a global, open-label, two-arm, randomized, Investigator’s Choice phase III registration study that is designed to investigate the efficacy and safety of radiotherapy-activated NBTXR3 with or without cetuximab versus radiotherapy with or without cetuximab in high-risk, chemotherapy-ineli
News | Radiation Therapy
First Patient Enrolled in NANORAY-312 Global Phase III Registrational Study of NBTXR3 in Head and Neck Cancer

January 10, 2022 — Nanobiotix, a late-stage clinical biotechnology company pioneering physics-based approaches to expand ...

Time January 10, 2022
arrow
Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021.
Feature | Radiology Business | By Melinda Taschetta-Millane
Top 10: Most Read Radiology Technology Content in December 2021

Here is a list of the Top 10 most read pieces of content on ITNonline.com from the month of December 2021. This is based ...

Time December 23, 2021
arrow
The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board of Directors Chair Laura A. Dawson, M.D., FASTRO, in response to today's introduction of the Supporting Health Care Providers During the COVID-19 Pandemic Act in the U.S. House of Representatives.
News | Radiation Oncology
ASTRO Urges Congress to Pass Legislation Delaying RO Model and Protecting Medicare Beneficiaries' Access to Care

December 9, 2021 — The American Society for Radiation Oncology (ASTRO) issued the following statement from ASTRO Board ...

Time December 09, 2021
arrow
Videos | Radiation Therapy
VIDEO: Sedating Children With Movies Rather Than Drugs for Radiation Therapy

Jeffrey T. Chapman, a medical student at the University of Texas Southwestern Medical Center, Explains how watching ...

Time November 24, 2021
arrow
Videos | Radiopharmaceuticals and Tracers
VIDEO: Advances in Radiopharmaceutical Therapy

Ana Kiess, M.D., Ph.D., assistant professor of radiation oncology and molecular radiation sciences, Johns Hopkins ...

Time November 17, 2021
arrow
Videos | Radiation Therapy
VIDEO: Elekta Harmony Radiotherapy System Walk-around

The Elekta Harmony radiotherapy system gained FDA clearance in the summer of 2021 and was on display for the first time ...

Time November 17, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of an Ion Beam Radiotherapy Treatment System

This is a model of the Toshiba ion beam radiation therapy system at the American Society of Radiation Oncology (ASTRO) ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: MRI-Linac and PSMA PET Imaging Technologies Aids Therapy at GenesisCare

Walter Curran, Jr. M.D., FACR, FASCO, GenesisCare global chief medical officer, discusses three technologies that are ...

Time November 16, 2021
arrow
Videos | Radiation Oncology
VIDEO: Example of a Multileaf Collimator (MLC) on a Radiotherapy System

This is an example of a multileaf collimator (MLC) on the Accuray Thomotherapy radiation therapy system at the American ...

Time November 16, 2021
arrow
Videos | Radiation Therapy
VIDEO: 4 Radiation Oncology Technologies to Watch

Anthony Zietman, M.D., interim chief, radiation oncology, Mass General Cancer Center, and former president of the ...

Time November 15, 2021
arrow
Videos | Radiation Therapy
VIDEO: Examples of Synthetic CT Datasets Made From MRI for Radiotherapy Treatment Planning

Siemens and Philips demonstrated examples of new imaging software to convert MRI datasets into synthetic computed ...

Time November 15, 2021
arrow
Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early-stage breast cancer, announced that the American Medical Association (AMA) has issued a new, dedicated current procedural terminology (CPT) proprietary laboratory analyses (PLA) code for DCISionRT, the only test available to predict personalized recurrence risk and radiation therapy benefit for patients with ductal carcinoma in situ (DCIS).
News | Radiation Oncology
American Medical Association Grants PreludeDx a CPT PLA Code for Proprietary DCISionRT Test

November 12, 2021 — Prelude Corporation (PreludeDx), a leader in molecular diagnostics and precision medicine for early ...

Time November 12, 2021
arrow
Videos | Oncology Information Management Systems (OIMS)
VIDEO Example of the Varian Noona Bidirection Oncology Patient Interface Software

An example of the Varian Noona software used by clinicians to interface with oncology patients demonstrated at the ...

Time November 12, 2021
arrow
Videos | Radiation Therapy
VIDEO: Reflexion Radiation Therapy System Walk-around at ASTRO 2021

This is Reflexion’s X1 LINAC radiotherapy system on display at ASTRO 2021. It recently gained FDA clearance for standard ...

Time November 11, 2021
arrow
Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology (ASTRO) 2021 Annual Meeting suggest the company’s Decipher Prostate genomic classifier identifies patients with clinically high-risk prostate cancer who may require treatment intensification beyond standard-of-care therapy
News | Prostate Cancer
Data Presented at ASTRO 2021 Validate Prognostic Value of Decipher Prostate Genomic Test in Newly Diagnosed, Clinically High-Risk Prostate Cancer

November 11, 2021 — Veracyte Inc. announced that new data being presented at the American Society for Radiation Oncology ...

Time November 11, 2021
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now